Fol. Biol. 2022, 68, 1-15

https://doi.org/10.14712/fb2022068010001

Ferroptosis-Related Long Noncoding RNA Signature Predicts Prognosis of Clear Cell Renal Carcinoma

J. W. Liu, F. Supandi, Sarinder Kaur Dhillon

Institute of Biological Sciences, Faculty of Science, University Malaya, Kuala Lumpur, Malaysia

Received August 2021
Accepted January 2022

References

1. American Cancer Society (2021) Cancer Facts and Figures 2021.
2. Baugh, E. H., Ke, H., Levine, A. J., Bonneau, R. A., Chan, C. S. (2018) Why are there hotspot mutations in the TP53 gene in human cancers? Cell Death Differ. 25, 154-160. <https://doi.org/10.1038/cdd.2017.180>
3. Carlevaro-Fita, J., Lanzós, A., Feuerbach, L., Hong, C., Mas-Ponte, D., Pedersen, J. S.; PCAWG Drivers and Functional Interpretation Group, Johnson, R.; PCAWG Consortium (2020) Cancer LncRNA Census reveals evidence for deep functional conservation of long noncoding RNAs in tumorigenesis. Commun. Biol. 3, 56. <https://doi.org/10.1038/s42003-019-0741-7>
4. Chen, X., Kang, R., Kroemer, G., Tang, D. (2021) Broadening horizons: the role of ferroptosis in cancer. Nature Rev. Clin. Oncol. 18, 280-296. <https://doi.org/10.1038/s41571-020-00462-0>
5. Choudhari, R., Sedano, M. J., Harrison, A. L., Subramani, R., Lin, K. Y., Ramos, E. I., Lakshmanaswamy, R., Gadad, S. S. (2020) Long noncoding RNAs in cancer: From discovery to therapeutic targets. Adv. Clin. Chem. 95, 105-147. <https://doi.org/10.1016/bs.acc.2019.08.003>
6. Dixon, S. J., Lemberg, K. M., Lamprecht, M. R., Skouta, R., Zaitsev, E. M., Gleason, C. E., Patel, D. N., Bauer, A. J., Cantley, A. M., Yang, W. S., Morrison, B., 3rd, Stockwell, B. R. (2012) Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060-1072. <https://doi.org/10.1016/j.cell.2012.03.042>
7. Eling, N., Reuter, L., Hazin, J., Hamacher-Brady, A., Brady, N. R. (2015) Identification of artesunate as a specific activator of ferroptosis in pancreatic cancer cells. Oncoscience 2, 517-532. <https://doi.org/10.18632/oncoscience.160>
8. Harrell, F. E. Jr. (2021) rms: Regression Modeling Strategies. Retrieved from https://CRAN.R-project.org/package=rms.
9. Hassannia, B., Vandenabeele, P., Vanden Berghe, T. (2019) Targeting ferroptosis to iron out cancer. Cancer Cell 35, 830-849. <https://doi.org/10.1016/j.ccell.2019.04.002>
10. Hauptman, N., Glavač, D. (2013) Long non-coding RNA in cancer. Int. J. Mol. Sci. 14, 4655-4669. <https://doi.org/10.3390/ijms14034655>
11. Heagerty, P. J., Saha-Chaudhuri, P. (2013) survivalROC: Time-dependent ROC curve estimation from censored survival data. Retrieved from https://CRAN.R-project.org/package=survivalROC
12. Hsieh, J. J., Purdue, M. P., Signoretti, S., Swanton, C., Albiges, L., Schmidinger, M., Heng, D. Y., Larkin, J., Ficarra, V. (2017) Renal cell carcinoma. Nature Rev. Dis. Primers 3, 17009. <https://doi.org/10.1038/nrdp.2017.9>
13. Jiang, L., Kon, N., Li, T., Wang, S. J., Su, T., Hibshoosh, H., Baer, R., Gu, W. (2015) Ferroptosis as a p53-mediated activity during tumour suppression. Nature 520, 57-62. <https://doi.org/10.1038/nature14344>
14. Jiang, M., Qiao, M., Zhao, C., Deng, J., Li, X., Zhou, C. (2020) Targeting ferroptosis for cancer therapy: exploring novel strategies from its mechanisms and role in cancers. Transl. Lung Cancer Res. 9, 1569-1584. <https://doi.org/10.21037/tlcr-20-341>
15. Kassambara, A., Kosinski, M., Biecek, P. (2021) survminer: Drawing Survival Curves using ‘ggplot2’. Retrieved from https://CRAN.R-project.org/package=survminer
16. Kuhn, M. (2020) caret: Classification and Regression Training. Retrieved from https://CRAN.R-project.org/package=caret
17. Li, J., Cao, F., Yin, H.-L., Huang, Z.-J., Lin, Z.-T., Mao, N., Sun, B., Wang, G. (2020a) Ferroptosis: past, present and future. Cell Death Dis. 11, 88. <https://doi.org/10.1038/s41419-020-2298-2>
18. Li, X., Zou, Y., Xing, J., Fu, Y.-Y., Wang, K.-Y., Wan, P.-Z., Zhai, X.-Y. (2020b) Pretreatment with roxadustat (FG-4592) attenuates folic acid-induced kidney injury through antiferroptosis via Akt/GSK-3β/Nrf2 pathway. Oxid. Med. Cell. Longev. 2020, 6286984.
19. Liang, J., Zhi, Y., Deng, W., Zhou, W., Li, X., Cai, Z., Zhu, Z., Zeng, J., Wu, W., Dong, Y., Huang, J., Zhang, Y., Xu, S., Feng, Y., Ding, F., Zhang, J. (2021) Development and validation of ferroptosis-related lncRNAs signature for hepatocellular carcinoma. PeerJ 9, e11627. <https://doi.org/10.7717/peerj.11627>
20. Liu, Y., Qian, J., Li, X., Chen, W., Xu, A., Zhao, K., Hua, Y., Huang, Z., Zhang, J., Liang, C., Su, S., Li, P., Shao, P., Li, J., Qin, C., Wang, Z. (2016) Long noncoding RNA BX357664 regulates cell proliferation and epithelial-to-mesenchymal transition via inhibition of TGF-β1/p38/HSP27 signaling in renal cell carcinoma. Oncotarget 7, 81410-81422. <https://doi.org/10.18632/oncotarget.12937>
21. Ljungberg, B., Bensalah, K., Canfield, S., Dabestani, S., Hofmann, F., Hora, M., Kuczyk, M. A., Lam, T., Marconi, L., Merseburger, A. S., Mulders, P., Powles, T., Staehler, M., Volpe, A., Bex, A. (2015) EAU guidelines on renal cell carcinoma: 2014 update. Eur. Urol. 67, 913-924. <https://doi.org/10.1016/j.eururo.2015.01.005>
22. Lu, B., Chen, X. B., Ying, M. D., He, Q. J., Cao, J., Yang, B. (2018) The role of ferroptosis in cancer development and treatment response. Front. Pharmacol. 8, 992-992. <https://doi.org/10.3389/fphar.2017.00992>
23. Lu, J., Xu, F., Lu, H. (2020) LncRNA PVT1 regulates ferroptosis through miR-214-mediated TFR1 and p53. Life Sci. 260, 118305. <https://doi.org/10.1016/j.lfs.2020.118305>
24. Ma, Q., Dai, X., Lu, W., Qu, X., Liu, N., and Zhu, C. (2021) Silencing long non-coding RNA MEG8 inhibits the proliferation and induces the ferroptosis of hemangioma endothelial cells by regulating miR-497-5p/NOTCH2 axis. Biochem. Biophys. Res. Commun. 556, 72-78. <https://doi.org/10.1016/j.bbrc.2021.03.132>
25. Mao, C., Wang, X., Liu, Y., Wang, M., Yan, B., Jiang, Y., Shi, Y., Shen, Y., Liu, X., Lai, W., Yang, R., Xiao, D., Cheng, Y., Liu, S., Zhou, H., Cao, Y., Yu, W., Muegge, K., Yu, H., Tao, Y. (2018) A G3BP1-interacting lncRNA promotes ferroptosis and apoptosis in cancer via nuclear sequestration of p53. Cancer Res. 78, 3484-3496. <https://doi.org/10.1158/0008-5472.CAN-17-3454>
26. Motzer, R. J., Jonasch, E., Agarwal, N., Beard, C., Bhayani, S., Bolger, G. B., Chang, S. S., Choueiri, T. K., Costello, B. A., Derweesh, I. H., Gupta, S., Hancock, S. L., Kim, J. J., Kuzel, T. M., Lam, E. T., Lau, C., Levine, E. G., Lin, D. W., Michaelson, M. D., Olencki, T., Pili, R., Plimack, E. R., Rampersaud, E. N., Redman, B. G., Ryan, C. J., Sheinfeld, J., Shuch, B., Sircar, K., Somer, B., Wilder, R. B., Dwyer, M., Kumar, R. (2015) Kidney cancer, version 3.2015. J. Natl. Compr. Canc. Netw. 13, 151-159. <https://doi.org/10.6004/jnccn.2015.0022>
27. Newman, A. M., Liu, C. L., Green, M. R., Gentles, A. J., Feng, W., Xu, Y., Hoang, C. D., Diehn, M., Alizadeh, A. A. (2015) Robust enumeration of cell subsets from tissue expression profiles. Nat. Methods 12, 453-457. <https://doi.org/10.1038/nmeth.3337>
28. Peng, W. X., Koirala, P., Mo, Y. Y. (2017) LncRNA-mediated regulation of cell signaling in cancer. Oncogene 36, 5661-5667. <https://doi.org/10.1038/onc.2017.184>
29. Ritchie, M. E., Phipson, B., Wu, D., Hu, Y., Law, C. W., Shi, W., Smyth, G. K. (2015) limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 43, e47. <https://doi.org/10.1093/nar/gkv007>
30. Schmitt, A. M., Chang, H. Y. (2016) Long noncoding RNAs in cancer pathways. Cancer Cell 29, 452-463. <https://doi.org/10.1016/j.ccell.2016.03.010>
31. Stockwell, B. R., Jiang, X. (2020) The chemistry and biology of ferroptosis. Cell Chem. Biol. 27, 365-375. <https://doi.org/10.1016/j.chembiol.2020.03.013>
32. Störkel, S., Eble, J. N., Adlakha, K., Amin, M., Blute, M. L., Bostwick, D. G., Darson, M., Delahunt, B., Iczkowski, K. (1997) Classification of renal cell carcinoma: Workgroup No. 1. Union Internationale Contre le Cancer (UICC) and the American Joint Committee on Cancer (AJCC). Cancer 80, 987-989. <https://doi.org/10.1002/(SICI)1097-0142(19970901)80:5<987::AID-CNCR24>3.0.CO;2-R>
33. Sung, H., Ferlay, J., Siegel, R. L., Laversanne, M., Soerjomataram, I., Jemal, A., Bray, F. (2021) Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209-249. <https://doi.org/10.3322/caac.21660>
34. Tang, B., Zhu, J., Li, J., Fan, K., Gao, Y., Cheng, S., Kong, C., Zheng, L., Wu, F., Weng, Q., Lu, C., Ji, J. (2020) The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma. Cell Commun. Signal. 18, 174. <https://doi.org/10.1186/s12964-020-00663-1>
35. Therneau, T. M., Grambsch, P. M. (2000) Modeling Survival Data: Extending the Cox Model. Springer-Verlag, New York.
36. Wang, M., Mao, C., Ouyang, L., Liu, Y., Lai, W., Liu, N., Shi, Y., Chen, L., Xiao, D., Yu, F., Wang, X., Zhou, H., Cao, Y., Liu, S., Yan, Q., Tao, Y., Zhang, B. (2019a) Long noncoding RNA LINC00336 inhibits ferroptosis in lung cancer by functioning as a competing endogenous RNA. Cell Death Differ. 26, 2329-2343. <https://doi.org/10.1038/s41418-019-0304-y>
37. Wang, W., Green, M., Choi, J. E., Gijón, M., Kennedy, P. D., Johnson, J. K., Liao, P., Lang, X., Kryczek, I., Sell, A., Xia, H., Zhou, J., Li, G., Li, J., Li, W., Wei, S., Vatan, L., Zhang, H., Szeliga, W., Gu, W., Liu, R., Lawrence, T. S., Lamb, C., Tanno, Y., Cieslik, M., Stone, E., Georgiou, G., Chan, T. A., Chinnaiyan, A., Zou, W. (2019b) CD8+ T cells regulate tumour ferroptosis during cancer immunotherapy. Nature 569, 270-274. <https://doi.org/10.1038/s41586-019-1170-y>
38. Wickham, H. (2016) ggplot2: Elegant Graphics for Data Analysis. Springer-Verlag, New York.
39. Xiao, J., Lv, Y., Jin, F., Liu, Y., Ma, Y., Xiong, Y., Liu, L., Zhang, S., Sun, Y., Tipoe, G. L., Hong, A., Xing, F., Wang, X. (2017) LncRNA HANR promotes tumorigenesis and increase of chemoresistance in hepatocellular carcinoma. Cell. Physiol. Biochem. 43, 1926-1938. <https://doi.org/10.1159/000484116>
40. Xu, L., Huan, L., Guo, T., Wu, Y., Liu, Y., Wang, Q., Huang, S., Xu, Y., Liang, L., He, X. (2020) LncRNA SNHG11 facilitates tumor metastasis by interacting with and stabilizing HIF-1α. Oncogene 39, 7005-7018. <https://doi.org/10.1038/s41388-020-01512-8>
41. Yang, W. S., SriRamaratnam, R., Welsch, M. E., Shimada, K., Skouta, R., Viswanathan, V. S., Cheah, J. H., Clemons, P. A., Shamji, A. F., Clish, C. B., Brown, L. M., Girotti, A. W., Cornish, V. W., Schreiber, S. L., Stockwell, B. R. (2014) Regulation of ferroptotic cancer cell death by GPX4. Cell 156, 317-331. <https://doi.org/10.1016/j.cell.2013.12.010>
42. Yang, Y., Tai, W., Lu, N., Li, T., Liu, Y., Wu, W., Li, Z., Pu, L., Zhao, X., Zhang, T., Dong, Z. (2020) lncRNA ZFAS1 promotes lung fibroblast-to-myofibroblast transition and ferroptosis via functioning as a ceRNA through miR-150-5p/SLC38A1 axis. Aging (Albany NY) 12, 9085-9102. <https://doi.org/10.18632/aging.103176>
43. Yu, G., Wang, L.-G., Han, Y., He, Q.-Y. (2012) clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16, 284-287. <https://doi.org/10.1089/omi.2011.0118>
44. Yu, H., Guo, P., Xie, X., Wang, Y., Chen, G. (2017) Ferroptosis, a new form of cell death, and its relationships with tumourous diseases. J. Cell. Mol. Med. 21, 648-657. <https://doi.org/10.1111/jcmm.13008>
45. Zhang, H., Qin, C., Liu, H. W., Guo, X., Gan, H. (2021) An effective hypoxia-related long non-coding RNAs assessment model for prognosis of clear cell renal carcinoma. Front. Oncol. 11, 616722. <https://doi.org/10.3389/fonc.2021.616722>
46. Zhou, L., Zhu, Y., Sun, D., Zhang, Q. (2020) Emerging roles of long non-coding RNAs in the tumor microenvironment. Int. J. Biol. Sci. 16, 2094-2103. <https://doi.org/10.7150/ijbs.44420>
47. Zhou, N., Bao, J. (2020) FerrDb: a manually curated resource for regulators and markers of ferroptosis and ferroptosis-disease associations. Database (Oxford) 2020, baaa021.
front cover

ISSN 0015-5500 (Print) ISSN 2533-7602 (Online)

Open access journal

Archive